The Webinar from yesterday. Some key points:
1. Funding with 4.77 million in cash plus R&D being announced next week
2. Phase 2 funding coming from the Department of Defence in America. They have non dilutive funding to not cause dilution
3. AGN works differently to NYR but the mechanism of reducing secondary brain injury is the same
4. Safety data continuing to come through
https://youtu.be/ijO5rj8hkeo?si=MtcKJVJa6Qmysgk0
Ann: Investor Presentation, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $164.0K | 1.456M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 742920 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 254495 | 3 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |